日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial

认知增强疗法对早期精神分裂症疗效的验证：一项多中心随机试验的结果

期刊:
影响因子:
doi:10.1176/appi.ps.202000552
Wojtalik, Jessica A; Mesholam-Gately, Raquelle I; Hogarty, Susan S; Greenwald, Deborah P; Litschge, Maralee Y; Sandoval, Luis R; Shashidhar, Gautami; Guimond, Synthia; Keshavan, Matcheri S; Eack, Shaun M
精神分裂症
神经科学
发表日期：2022
文献求助 收藏

Cognitive enhancement therapy for adult autism spectrum disorder: Results of an 18-month randomized clinical trial

成人自闭症谱系障碍的认知增强疗法：一项为期18个月的随机临床试验结果

期刊:Autism Research
影响因子:5.6
doi:10.1002/aur.1913
Eack, Shaun M; Hogarty, Susan S; Greenwald, Deborah P; Litschge, Maralee Y; Porton, Shannondora A; Mazefsky, Carla A; Minshew, Nancy J
自闭症
神经科学
发表日期：2018
文献求助 收藏

Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial

认知增强疗法治疗物质滥用型精神分裂症：一项为期18个月的可行性试验结果

期刊:Schizophrenia Research
影响因子:3.5
doi:10.1016/j.schres.2014.11.017
Eack, Shaun M; Hogarty, Susan S; Greenwald, Deborah P; Litschge, Maralee Y; McKnight, Summer A F; Bangalore, Srihari S; Pogue-Geile, Michael F; Keshavan, Matcheri S; Cornelius, Jack R
精神分裂症
神经科学
发表日期：2015
文献求助 收藏

Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy

简报：有语言能力的自闭症成年人是否需要认知康复？一项认知增强疗法试验的初步入组结果提供的见解

期刊:Journal of Autism and Developmental Disorders
影响因子:2.8
doi:10.1007/s10803-013-1774-2
Eack, Shaun M; Bahorik, Amber L; Hogarty, Susan S; Greenwald, Deborah P; Litschge, Maralee Y; Mazefsky, Carla A; Minshew, Nancy J
自闭症
神经科学
发表日期：2013
文献求助 收藏

Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study

针对自闭症谱系障碍成人患者的认知增强疗法：一项为期18个月的可行性研究结果

期刊:Journal of Autism and Developmental Disorders
影响因子:2.8
doi:10.1007/s10803-013-1834-7
Eack, Shaun M; Greenwald, Deborah P; Hogarty, Susan S; Bahorik, Amber L; Litschge, Maralee Y; Mazefsky, Carla A; Minshew, Nancy J
自闭症
神经科学
发表日期：2013
文献求助 收藏

Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET

利用PET测定D2/3受体激动剂11C-N-丙基去甲阿朴吗啡（11C-NPA）在人体内的生物分布和剂量学。

期刊:Journal of Nuclear Medicine
影响因子:9.1
doi:10.2967/jnumed.108.058131
Laymon, Charles M; Mason, N Scott; Frankle, W Gordon; Carney, Jonathan P; Lopresti, Brian J; Litschge, Maralee Y; Mathis, Chester A; Mountz, James M; Narendran, Rajesh
信号转导
Human
发表日期：2009
文献求助 收藏

Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects

在健康对照受试者中，噻加宾可增加皮质脑区中[11C]氟马西尼的结合。

期刊:Neuropsychopharmacology
影响因子:7.1
doi:10.1038/npp.2008.104
Frankle, W Gordon; Cho, Raymond Y; Narendran, Rajesh; Mason, N Scott; Vora, Shivangi; Litschge, Maralee; Price, Julie C; Lewis, David A; Mathis, Chester A
神经科学
发表日期：2009
文献求助 收藏

Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies

利用放射性示踪剂[(11)C]-N-丙基-去甲阿扑吗啡对健康人体受试者体内D(2/3)受体激动剂结合进行正电子发射断层扫描成像：初步评估和重复性研究

期刊:Synapse
影响因子:2
doi:10.1002/syn.20633
Narendran, Rajesh; Frankle, W Gordon; Mason, N Scott; Laymon, Charles M; Lopresti, Brian J; Price, Julie C; Kendro, Steve; Vora, Shivangi; Litschge, Maralee; Mountz, James M; Mathis, Chester A
信号转导
发表日期：2009
文献求助 收藏